Nantahala Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-35,600
Closed -$8.92M 127
2022
Q1
$8.92M Hold
35,600
0.39% 46
2021
Q4
$9.15M Hold
35,600
0.32% 61
2021
Q3
$8.64M Hold
35,600
0.27% 70
2021
Q2
$7.36M Hold
35,600
0.21% 81
2021
Q1
$6.71M Sell
35,600
-15,717
-31% -$2.77M 0.2% 75
2020
Q4
$8.44M Sell
51,317
-131
-0.3% -$19.2K 0.26% 76
2020
Q3
$6.42M Sell
51,448
-245,551
-83% -$30.4M 0.2% 78
2020
Q2
$28.8M Sell
296,999
-22,435
-7% -$2.33M 0.87% 31
2020
Q1
$28.7M Buy
+319,434
New +$41.4M 1.07% 25

Other funds holding HCA

Nantahala Capital Management's HCA Position: Q2 2022 in Review

Nantahala Capital Management sold out of HCA Healthcare (HCA) in Q2 2022, closing a stake of 35,600 shares — an estimated $8.92M sold.

Nantahala Capital Management first reported a position in HCA in Q1 2020 and held it in 9 quarters. The position peaked at $28.8M in Q2 2020. 883 funds tracked by Wall St. Rank hold HCA as of Q2 2022.

  • Nantahala Capital Management reported no remaining HCA Healthcare position as of Q2 2022 after selling out during the quarter.
  • Nantahala Capital Management sold 35,600 HCA Healthcare shares in Q2 2022, an estimated $8.92M.
  • Nantahala Capital Management first reported a position in HCA Healthcare in Q1 2020 and held it in 9 quarters.
  • Nantahala Capital Management's HCA Healthcare position peaked at $28.8M in Q2 2020.
  • 883 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2022.

Based on Nantahala Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.